{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T06:50:39Z","timestamp":1648795839995},"reference-count":8,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mdconsult.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.pupt.2014.03.007","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T04:30:27Z","timestamp":1400128227000},"page":"89","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inaccurate data in meta-analysis of macrolides by Guang-Ying et\u00a0al"],"prefix":"10.1016","volume":"29","author":[{"given":"D.J.","family":"Serisier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2014.03.007_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pupt.2014.02.002","article-title":"Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized-controlled trials","volume":"29","author":"Guang-Ying","year":"2014","journal-title":"Pulm Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.pupt.2014.03.007_bib2","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis. The BLESS randomized controlled trial","volume":"309","author":"Serisier","year":"2013","journal-title":"JAMA"},{"issue":"9842","key":"10.1016\/j.pupt.2014.03.007_bib3","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2014.03.007_bib4","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"Altenburg","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.pupt.2014.03.007_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/resp.12233","article-title":"Long-term macrolides for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis","volume":"19","author":"Wu","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.pupt.2014.03.007_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/resp.12247","article-title":"The evidence base for non-CF bronchiectasis is finally evolving","volume":"19","author":"Serisier","year":"2014","journal-title":"Respirology"},{"issue":"3","key":"10.1016\/j.pupt.2014.03.007_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S2213-2600(13)70038-9","article-title":"Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases","volume":"1","author":"Serisier","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.pupt.2014.03.007_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pupt.2013.12.006","article-title":"Letter to the editor: Inaccurate data in meta-analysis of macrolides by Shi et\u00a0al","volume":"28","author":"Serisier","year":"2014","journal-title":"Pulm Pharmacol Ther"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553914000492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553914000492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T00:59:10Z","timestamp":1538614750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553914000492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1094553914000492"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2014.03.007","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inaccurate data in meta-analysis of macrolides by Guang-Ying et\u00a0al","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2014.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}